531 related articles for article (PubMed ID: 24607436)
1. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function.
Neyt S; Vliegen M; Verreet B; De Lombaerde S; Braeckman K; Vanhove C; Huisman MT; Dumolyn C; Kersemans K; Hulpia F; Van Calenbergh S; Mannens G; De Vos F
Nucl Med Biol; 2016 Oct; 43(10):642-9. PubMed ID: 27513813
[TBL] [Abstract][Full Text] [Related]
3. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
4. OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker.
Nakagomi-Hagihara R; Nakai D; Kawai K; Yoshigae Y; Tokui T; Abe T; Ikeda T
Drug Metab Dispos; 2006 May; 34(5):862-9. PubMed ID: 16501004
[TBL] [Abstract][Full Text] [Related]
5. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green.
de Graaf W; Häusler S; Heger M; van Ginhoven TM; van Cappellen G; Bennink RJ; Kullak-Ublick GA; Hesselmann R; van Gulik TM; Stieger B
J Hepatol; 2011 Apr; 54(4):738-45. PubMed ID: 21163547
[TBL] [Abstract][Full Text] [Related]
6. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
7. In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.
Neyt S; Huisman MT; Vanhove C; De Man H; Vliegen M; Moerman L; Dumolyn C; Mannens G; De Vos F
J Nucl Med; 2013 Apr; 54(4):624-30. PubMed ID: 23440558
[TBL] [Abstract][Full Text] [Related]
8. Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers.
Liu L; Cui Y; Chung AY; Shitara Y; Sugiyama Y; Keppler D; Pang KS
J Pharmacol Exp Ther; 2006 Jul; 318(1):395-402. PubMed ID: 16627748
[TBL] [Abstract][Full Text] [Related]
9. Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin.
Kitamura S; Maeda K; Wang Y; Sugiyama Y
Drug Metab Dispos; 2008 Oct; 36(10):2014-23. PubMed ID: 18617601
[TBL] [Abstract][Full Text] [Related]
10. Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.
Ghibellini G; Leslie EM; Pollack GM; Brouwer KL
Pharm Res; 2008 Aug; 25(8):1851-60. PubMed ID: 18509604
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.
Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273
[TBL] [Abstract][Full Text] [Related]
12. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
[TBL] [Abstract][Full Text] [Related]
13. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
[TBL] [Abstract][Full Text] [Related]
14. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
15. Transport mechanism and affinity of [99mTc]Tc-mercaptoacetyltriglycine ([99mTc]MAG3) on the apical membrane of renal proximal tubule cells.
Kobayashi M; Nishi K; Mizutani A; Okudaira H; Nakanishi T; Shikano N; Nishii R; Tamai I; Kawai K
Nucl Med Biol; 2020; 84-85():33-37. PubMed ID: 31986465
[TBL] [Abstract][Full Text] [Related]
16. Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin.
Bhargava KK; Joseph B; Ananthanarayanan M; Balasubramaniyan N; Tronco GG; Palestro CJ; Gupta S
J Nucl Med; 2009 Jul; 50(7):1140-6. PubMed ID: 19525466
[TBL] [Abstract][Full Text] [Related]
17. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism.
Sheng J; Tian X; Xu G; Wu Z; Chen C; Wang L; Pan L; Huang C; Pan G
Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of hepatobiliary scintigraphy using 99m Tc-N-pyridoxyl-5-methyltryptophan (PMT)].
Aburano T; Ohguchi M; Kuwajima A; Tonami N; Hisada K
Kaku Igaku; 1983 Apr; 20(3):353-60. PubMed ID: 6632363
[No Abstract] [Full Text] [Related]
19. The Effects of Drug Metabolizing Enzyme Inhibitors on Hepatic Efflux and Uptake Transporters.
Cheong J; Halladay JS; Plise E; Sodhi JK; Salphati L
Drug Metab Lett; 2017; 11(2):111-118. PubMed ID: 29032766
[TBL] [Abstract][Full Text] [Related]
20. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
